Chimeric Antigen Receptor T Regulatory Cells for the Treatment of Atherosclerosis
AssigneeThe Trustees of the University of Pennsylvania
InventorsAvery D. POSEY, Carl H. JUNE, Robert D. SCHWAB
Life of this patent
Estimating the term…
Abstract
The present invention includes compositions and methods for treating atherosclerosis. In certain embodiments, atherosclerosis is treated using a chimeric antigen receptor (CAR) T cell specific for modified low-density lipoprotein.
Claims61
A method for treating heart disease and/or atherosclerosis in a subject in need thereof, the method comprising administering to the subject a T cell genetically modified to express a chimeric antigen receptor (CAR), wherein the CAR comprises an antigen binding domain specific for modified low-density lipoprotein (LDL), a transmembrane domain, and an intracellular domain.
An isolated chimeric antigen receptor (CAR) comprising an antigen binding domain specific for modified low-density lipoprotein (LDL), a transmembrane domain, and an intracellular domain.
Dependencies are inferred from the claim text.